Bnp Paribas Asset Management Holding S.A. Sarepta Therapeutics, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$72.25 - $168.95 $11.3 Million - $26.4 Million	-156,433 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $2.37 Million - $3.38 Million	18,915 Added 13.75%	156,433 $26.7 Million
Q3 2020 Nov 09, 2020	BUY	$127.12 - $172.34 $7.35 Million - $9.97 Million	57,852 Added 72.62%	137,518 $19.3 Million
Q2 2020 Aug 04, 2020	SELL	$93.0 - $171.7 $4.14 Million - $7.65 Million	-44,530 Reduced 35.85%	79,666 $12.8 Million
Q1 2020 May 12, 2020	SELL	$82.38 - $131.64 $482,993 - $771,805	-5,863 Reduced 4.51%	124,196 $12.1 Million
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $3.38 Million - $5.99 Million	44,164 Added 51.42%	130,059 $16.8 Million
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $1.07 Million - $2.3 Million	-14,682 Reduced 14.6%	85,895 $6.47 Million
Q2 2019 Aug 02, 2019	BUY	$112.21 - $151.95 $865,812 - $1.17 Million	7,716 Added 8.31%	100,577 $15.3 Million
Q1 2019 Apr 26, 2019	BUY	$106.67 - $151.68 $9.91 Million - $14.1 Million	92,861 New	92,861 $11.1 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.